Report title: Cumberland Pharmaceuticals Inc.
from SharkRepellent.net
7 page (3577 word) report published Nov 23, 2009

Price $150.00 available for immediate download
Report Overview
 
Search Inside
 
About SharkRepellent.net

...Sections 48-103-201 to 48-103-209 of the TBCA (the "Tennessee Business Combination Act") provides that a covered corporation can not engage in any business combinations with an interested shareholder (beneficial owner of 10% of the voting power) for five years unless the transaction resulting in a person becoming an interested shareholder, or the business combination, is approved by the board of directors of the corporation prior to that person becoming an interested shareholder. After the five-year restricted period, the interested shareholder may effect a business combination if the combination is approved by 2/3 of the outstanding voting stock not beneficially owned by the interested stockholder or if certain fair price requirements are met. The company has not opted out of this provision. ("Freezeout with fair price provision") Section 48-16-205 of the TBCA endorses the use of shareholder rights plans ("poison pills") for in-state companies....

Source: SharkRepellent.net
Ticker: CPIX
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $150.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.